Home > Insider Trading > Filing (0001110803-13-000220)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1110803	Illumina Inc	ILMN	Laboratory Analytical Instruments (3826)	330804655

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1205236	R David Walt	5200 Illumina Way San Diego CA 92122		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2013-05-29	4,800	$70.90	964,188	No	4	S	Direct
Common Stock	Disposition	2013-05-29	200	$71.41	963,988	No	4	S	Direct
Common Stock	Acquisiton	2013-05-29	2,500	$0.00	966,488	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	A	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Acquisiton	2013-05-29	7,600	$0.00	7,600	$71.09

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
7,600	2014-05-29	2023-05-29	No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	82,960	Indirect	By Spouse

Footnotes

The sale was made pursuant to a 10b5-1 plan.
Weighted average sale price representing 4,800 shares sold ranging from $70.38 to $71.34 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
Weighted average sale price representing 200 shares sold ranging from $71.38 to $71.44 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date.
100% of the shares subject to the option shall vest and become exercisable on the earlier of (i) the one year anniversary of the date of grant of the option and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the option, provided, in each case, that the optionee continues to serve as a director on such date.